I just posted this on Yahoo and thought it was worth

New Post Public Reply Private Reply Replies (0) Message Board
ibmiked Riztheinvestor #82504
561
I just posted this on Yahoo and thought it was worth sharing here.

As I have a significant position in CYDY I can't say that I wasn't disappointed that CD12 did not merit an EUA in the eyes of the FDA. However between the 2 press releases, the Saturday night Dr. Been interview, and the conference call on Monday I believe that Nader said something that was missed. I'm not quoting him directly as I haven't the time to parse out the exact language.

He frequently uses the words 'approval' and 'authorization' and I think most shareholders think of those words interchangeably. That could be a function of Nader's somewhat broken English. I don't fault him for that, but it comes across even in the press releases, where his grammar shows that he is not a native English speaker.

On a side note, I believe that those printed grammatical errors are further proof that Nader is writing the press releases himself, with little or no oversight aside from the legal department. If ever a company could benefit from a proper press officer who can proofread and edit for clarity, it is Cytodyn. The messaging is so bad that shareholders often confuse good news for bad (although never the reverse unfortunately).

Back to my point. Approval is not the same as Authorization. Right now, all of the therapeutics for Covid-19 aside from dexamethasone are being used under the very conditional Emergency Use Authorization. This authorization gets rescinded when either the pandemic is declared over, or a BETTER DRUG GETS EUA for the same use/population.

Nader said on Monday that they may apply for 'conditional FDA authorization' while waiting for CD16 to complete. I think that management was discussing actual Approval with the FDA prior to CD12 readout because of the massive amount of drug data acquired from the HIV trials and the rolling BLA for that indication. When the results were only in line with previous EUAs (see Dr. Been's recent comments), the FDA suggested the CD16 trial design.

To be clear, I think they have been talking about Approval all along while we as shareholders have been tying our hopes to Authorization. They hired Dr. Mahboob U. Rahman to get the HIV BLA in shape but that has become a corporate priority that seems to have slipped further and further down the timeline. I believe that is because Dr. Rahman is using the rolling review for that BLA to build an entirely new BLA around Covid-19. The missing piece would only be trial data, something that after CD12 we now know needs to be filled with data from CD16. Remember, the other parts of a BLA (manufacturing, safety data, etc.) are universal and not specific to the indication being applied for.

If true, the importance of this can't be overstated. With an EUA for Covid-19 we are subject to losing the market for Leronlimab if the pandemic is downgraded or if another drug proves better efficacy in our target patient population. If management is in fact angling for Approval with a conditional Authorization to hold us over, then a successful CD16 means the race could be won without us even knowing.

Or maybe Nader just confuses the word 'approval' with 'authorization'. At this point anything is possible. Good luck longs.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Blue Diamond's $1 Billion Brand Meets Farm Realities

Updated Category News Views 126

A Ten-Cent Signal Carries Real Weight A ten-cent edge over the industry benchmark may not excite the cocktail-party crowd, but almond growers notice every penny when fertilizer, power and pest control keep gnawing at the farm gate. Blue Diamond Growers says it delivered payments roughly 10 cents above the benchmark in its latest year, alongside net profit that came in...

Continue Reading
A Quanzhou Table Offers China Beyond the Headlines

Updated Category News Views 35

Steam rising from a Quanzhou table can carry more weight than another polished speech about cultural exchange. That is the sensible instinct behind Home Banquets with Master Chefs, the CCTV-4 series using regional meals to explore geography, customs and memory. It is not trying to explain China through a pile of statistics or a museum-label summary. It starts where people...

Continue Reading
Rosengart's Repeat Honor Signals Litigation Bench Depth

Updated Category News Views 196

Hollywood lawsuits rarely stay tucked inside a filing cabinet; they spill into headlines, contracts, careers, and sometimes a company's whole public posture. That is why Mathew S. Rosengart landing on The Hollywood Reporter's Top 25 Legal Troubleshooters list for a second straight year is more than a pleasant plaque for the office wall. It is a reminder that, in media and...

Continue Reading
COSCO Shipping Uses CIIE to Put People in the Chain

Updated Category News Views 87

A Supply Chain Is Not Just Steel and Schedules Containers do not shake hands, but the people routing them certainly do. That was the useful, rather human point underneath COSCO SHIPPING's presence at the ninth China International Import Expo in Shanghai: global logistics is a physical business built on relationships that have to survive different languages, markets,...

Continue Reading
Borr’s Q3 Presentation Puts Jack-Up Investors on Watch

Updated Category News Views 39

Jack-up drilling is a rough business to judge from a calendar invite, but Borr Drilling has put a useful marker in the sand. The company is scheduled to present financial results for the three and nine months ended September 30, 2026, at 09:00 New York time, or 15:00 CET, on Thursday, November 19. For holders of BORR, this is less about ceremonial webcast chatter and more...

Continue Reading
MegaRobo's Nearly $200 Million Bet on Learning Labs

Updated Category News Views 115

A lab robot that merely follows instructions is old news; a system that learns from the mess it makes is the expensive part. MegaRobo has raised nearly US$200 million to push toward that harder prize: infrastructure that links AI reasoning to actual experiments, instruments, automation and the results that come back. For investors watching AI for Science, this is more...

Continue Reading
Health In Tech Gets a Real Distribution Test in 2027

Updated Category News Views 97

A 100,000-employee funnel is the sort of number that makes a small InsurTech investor sit up, then reach for the fine print. Health In Tech has brought a national third-party administrator onto its eDIYBS platform, giving the company access to a TPA serving more than 650 employers in over 40 states, with more than 100,000 covered employees as of May 2026. That is...

Continue Reading
LianLian XWorker Brings AI Agents Into Global Payments

Updated Category News Views 74

Most AI launches promise a clever helper; this one wants the helper holding a tightly controlled wallet. Lianlian DigiTech unveiled LianLian XWorker at Singapore FinTech Festival 2026 on November 19, pitching an AI Workforce platform that joins task-running agents with its global financial plumbing. That is a much more consequential proposition than another chatbot that...

Continue Reading
ROHM's GaN PFC Chip Targets the Power-Supply Squeeze

Updated Category News Views 48

Power supplies are where a lot of sleek electronics quietly lose the plot, and ROHM is taking a proper swing at that problem. Its new BM85060FV is a totem-pole power factor correction controller built for gallium nitride, or GaN, high-frequency switching in AC-DC power supplies. The headline is not subtle: ROHM says a 300 to 500 W system using the chip can reach 99%...

Continue Reading
Frosty Animatronics Put Nostalgia on Lowe's Shelves

Updated Category News Views 142

A moving corncob pipe is not anybody's idea of a macroeconomic signal, yet holiday aisles are built on precisely these little jolts of recognition. Gemmy has teamed with Warner Bros. Discovery Global Consumer Products to place a new animated Frosty the Snowman collection exclusively at Lowe's for the 2026 holiday season. It is cheerful retail business, not earthshaking...

Continue Reading

Top 5 Most Recently Viewed Articles

Business Jet Steals the Spotlight with Starlink Installation

Updated Category News Views 350

Business Jet Achieves Significant Milestone with Starlink Business Jet has proudly completed the first installation of Starlink on the Embraer Legacy 600 certification aircraft. This innovative achievement signifies a major step in enhancing the inflight connectivity experience for clients, marking the Legacy 600 as a pioneer aircraft equipped with Starlink capabilities....

Continue Reading
Understanding the Importance of Snow Removal for Roof Safety

Updated Category News Views 166

Understanding the Importance of Roof Snow Removal When it comes to maintaining the safety of your home during winter, one crucial task often overlooked is roof snow removal. Roofing expert John Kolarik from Mariage Roofing shares valuable insights on why homeowners should be proactive about this important aspect of winter maintenance. Removing snow from roofs not only...

Continue Reading
Teck Resources Plans Significant Share Buyback Initiative

Updated Category News Views 126

Teck Resources Limited's Normal Course Issuer Bid Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) has exciting news as it prepares to initiate a normal course issuer bid aimed at repurchasing its Class B subordinate voting shares. With the Toronto Stock Exchange’s approval, Teck is set to purchase up to 40 million of these shares, equating to roughly 7.9% of...

Continue Reading
SR Bancorp Sees Fluctuations in Quarterly Income Performance

Updated Category News Views 192

Introduction to SR Bancorp, Inc. SR Bancorp, Inc. (NASDAQ: SRBK), the holding company for Somerset Regal Bank, has recently published its quarterly financial results, reflecting changes in net income and asset growth. In the most recent quarter, the company demonstrated resilience and adaptability amidst fluctuating market conditions. Net Income Overview Financial Results...

Continue Reading
Reddit Inc's Stock Surges: Navigating Mispricing and Strategies

Updated Category News Views 146

Reddit Inc Experiences Remarkable Stock Surge After being under pressure for much of the spring, shares of Reddit Inc (NYSE: RDDT) have rebounded dramatically. The stock experienced a surge of over 50% within a span of just two weeks, decisively breaking out of its previous trading range and reaching all-time highs. This notable rebound is striking, especially considering...

Continue Reading